Scarica l'app Stockscreener
1.77
3.51%
0.06
Dopo l'orario di chiusura:
1.84
0.07
+3.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZNTL Giù?
Forum
Previsione
Precedente Chiudi:
$1.71
Aprire:
$1.71
Volume 24 ore:
1.05M
Relative Volume:
1.09
Capitalizzazione di mercato:
$127.68M
Reddito:
-
Utile/perdita netta:
$-292.19M
Rapporto P/E:
-0.3899
EPS:
-4.54
Flusso di cassa netto:
$-208.41M
1 W Prestazione:
+0.57%
1M Prestazione:
+27.34%
6M Prestazione:
-5.35%
1 anno Prestazione:
-45.54%
Intervallo 1D:
$1.60
$1.79
Intervallo di 1 settimana:
$1.60
$1.82
Portata 52W:
$1.01
$5.44
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Nome
Zentalis Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 263-4333
Indirizzo
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Confronta ZNTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
1.77 | 124.07M | 0 | -292.19M | -208.41M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-12 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2024-06-20 | Downgrade | UBS | Buy → Neutral |
| 2024-06-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-18 | Downgrade | Wedbush | Neutral → Underperform |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-11-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2022-07-12 | Iniziato | Cowen | Outperform |
| 2022-04-06 | Iniziato | Wells Fargo | Overweight |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-29 | Iniziato | Oppenheimer | Outperform |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-01-20 | Iniziato | Wedbush | Outperform |
| 2020-09-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-28 | Iniziato | Guggenheim | Buy |
| 2020-04-28 | Iniziato | Jefferies | Buy |
| 2020-04-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-04-28 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie
Zentalis Pharmaceuticals shares fall 1.45% intraday after announcing inducement grants to new employees. - AInvest
Why Zentalis Pharmaceuticals Inc. is moving todayTrade Volume Report & Short-Term High Return Ideas - Newser
Using R and stats models for Zentalis Pharmaceuticals Inc. forecastingJuly 2025 Retail & Growth Focused Stock Reports - Newser
Using data tools to time your Zentalis Pharmaceuticals Inc. exitSwing Trade & Community Trade Idea Sharing - Newser
Zentalis Pharmaceuticals Inc. stock momentum explainedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Will Zentalis Pharmaceuticals Inc. stock recover after earningsJuly 2025 Breakouts & Risk Managed Investment Strategies - khodrobank.com
Using Ichimoku Cloud for Zentalis Pharmaceuticals Inc. technicalsQuarterly Performance Summary & Reliable Price Breakout Signals - Newser
Published on: 2025-09-03 05:20:27 - Newser
Will Zentalis Pharmaceuticals Inc. outperform small cap indexesWeekly Profit Analysis & Safe Capital Growth Tips - khodrobank.com
How to use Fibonacci retracement on Zentalis Pharmaceuticals Inc.Trade Risk Summary & Long-Term Capital Growth Ideas - Newser
Using portfolio simulators with Zentalis Pharmaceuticals Inc. includedJuly 2025 Reactions & Safe Capital Growth Plans - Newser
Is Zentalis Pharmaceuticals Inc. impacted by rising ratesCEO Change & Safe Investment Capital Preservation Plans - khodrobank.com
Heatmap analysis for Zentalis Pharmaceuticals Inc. and competitorsBuy Signal & Real-Time Volume Surge Alerts - Newser
Advanced analytics toolkit walkthrough for Zentalis Pharmaceuticals Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - Newser
Understanding Zentalis Pharmaceuticals Inc.’s price movementJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Can Zentalis Pharmaceuticals Inc. deliver consistent EPS growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - khodrobank.com
Tools to monitor Zentalis Pharmaceuticals Inc. recovery probabilityBuy Signal & Accurate Buy Signal Notifications - Newser
Zentalis Pharmaceuticals announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Zentalis Pharmaceuticals Grants Stock Options to New Employees as Part of Inducement Plan - Quiver Quantitative
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
381,000 Shares: Zentalis Pharmaceuticals Awards Major Stock Options Package to New Executive Hires - Stock Titan
What are the risks of holding Zentalis Pharmaceuticals Inc.Earnings Beat & Long-Term Growth Plans - khodrobank.com
Can Zentalis Pharmaceuticals Inc. weather a recessionJuly 2025 Levels & Community Driven Trade Alerts - khodrobank.com
Is Zentalis Pharmaceuticals Inc. stock showing strong momentumJuly 2025 Opening Moves & Stock Portfolio Risk Management - khodrobank.com
Can volume confirm reversal in Zentalis Pharmaceuticals Inc.Market Risk Summary & Proven Capital Preservation Methods - Newser
Is Zentalis Pharmaceuticals Inc. forming a bullish divergence2025 Technical Patterns & Weekly Stock Performance Updates - khodrobank.com
Long term hold vs stop loss in Zentalis Pharmaceuticals Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Zentalis Pharmaceuticals Inc. stock outlook for YEARWeekly Trade Recap & Consistent Income Trade Recommendations - Newser
What to do if you’re stuck in Zentalis Pharmaceuticals Inc.Trade Risk Report & Long-Term Safe Investment Plans - Newser
Should you hold or exit Zentalis Pharmaceuticals Inc. nowMarket Sentiment Review & Stock Portfolio Risk Management - Newser
Tick level data insight on Zentalis Pharmaceuticals Inc. volatilityWeekly Investment Report & Entry Point Confirmation Signals - Newser
Published on: 2025-08-31 06:27:08 - Newser
Technical signs of recovery in Zentalis Pharmaceuticals Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Sector Rotation Brings Zentalis Pharmaceuticals Inc. Into Focus getLinesFromResByArray error: size == 0 - 더경남뉴스
Visualizing Zentalis Pharmaceuticals Inc. stock with heatmapsJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zentalis Pharmaceuticals Inc Azioni (ZNTL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bruns Ingmar | Chief Medical Officer |
Feb 06 '25 |
Buy |
2.28 |
20,000 |
45,656 |
36,629 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):